This study reinforces the notion that patients with mutations in both RP1 alleles present severe early-onset RP with macular atrophy compared to patients with only one pathogenic variant who present late-onset and slowly progressing forms of the disease2,13. This evidence concerns the gene RP1 and retinitis pigmentosa 1.